Mandatum Life Insurance Co Ltd Acquires New Holdings in Lemonade, Inc. $LMND

Key Points

• Mandatum Life Insurance Co Ltd has acquired a new stake of 4,600 shares in Lemonade, Inc., valued at approximately $202,000 during Q2.
• Lemonade's stock has seen significant institutional activity, with major hedge funds raising their positions, indicating a growing interest in the company.
• Despite reporting a negative EPS of ($0.60), Lemonade's revenue increased by 34.5% year-over-year, suggesting potential for future growth.

Mandatum Life Insurance Co Ltd purchased a new stake in shares of Lemonade, Inc. (NYSE:LMND - Free Report) in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm purchased 4,600 shares of the company's stock, valued at approximately $202,000.

Other large investors have also bought and sold shares of the company. Caxton Associates LLP purchased a new position in shares of Lemonade in the first quarter valued at $1,455,000. Nomura Holdings Inc. bought a new stake in Lemonade during the first quarter worth about $416,000. Dynamic Technology Lab Private Ltd bought a new stake in Lemonade during the first quarter worth about $638,000. GAMMA Investing LLC lifted its stake in Lemonade by 35,901.8% during the first quarter. GAMMA Investing LLC now owns 19,801 shares of the company's stock worth $630,000 after purchasing an additional 19,746 shares during the last quarter. Finally, Halter Ferguson Financial Inc. lifted its stake in shares of Lemonade by 62.8% in the 1st quarter. Halter Ferguson Financial Inc. now owns 476,764 shares of the company's stock valued at $14,985,000 after acquiring an additional 183,974 shares during the last quarter. 80.30% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other Lemonade news, COO Adina Eckstein sold 5,000 shares of the stock in a transaction on Tuesday, August 5th. The shares were sold at an average price of $49.00, for a total transaction of $245,000.00. Following the transaction, the chief operating officer directly owned 189,653 shares in the company, valued at $9,292,997. This represents a 2.57% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, insider John Sheldon Peters sold 2,718 shares of the stock in a transaction on Wednesday, September 3rd. The stock was sold at an average price of $50.34, for a total transaction of $136,824.12. Following the sale, the insider directly owned 102,397 shares in the company, valued at $5,154,664.98. This trade represents a 2.59% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 8,000 shares of company stock valued at $396,020. Company insiders own 14.70% of the company's stock.

Lemonade Stock Down 2.1%

Lemonade stock traded down $1.26 during mid-day trading on Monday, reaching $59.70. 3,230,842 shares of the company's stock were exchanged, compared to its average volume of 2,333,833. Lemonade, Inc. has a twelve month low of $15.27 and a twelve month high of $61.82. The company has a fifty day moving average of $49.23 and a 200-day moving average of $39.45. The company has a market cap of $4.41 billion, a P/E ratio of -21.09 and a beta of 2.28.

Lemonade (NYSE:LMND - Get Free Report) last posted its earnings results on Tuesday, August 5th. The company reported ($0.60) EPS for the quarter, beating analysts' consensus estimates of ($0.81) by $0.21. The firm had revenue of $164.10 million for the quarter, compared to the consensus estimate of $160.88 million. Lemonade had a negative net margin of 33.96% and a negative return on equity of 36.12%. The company's revenue was up 34.5% on a year-over-year basis. During the same period last year, the firm posted ($0.81) EPS. Lemonade has set its FY 2025 guidance at EPS. Q3 2025 guidance at EPS. Equities research analysts expect that Lemonade, Inc. will post -3.03 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of research analysts have weighed in on the company. Wall Street Zen upgraded Lemonade from a "sell" rating to a "hold" rating in a report on Saturday, August 9th. Keefe, Bruyette & Woods reissued an "underperform" rating and set a $26.00 price target (up from $22.00) on shares of Lemonade in a report on Tuesday, July 1st. Morgan Stanley reiterated an "underweight" rating on shares of Lemonade in a research report on Monday, August 18th. Piper Sandler lifted their price target on shares of Lemonade from $55.00 to $60.00 and gave the company a "neutral" rating in a research note on Wednesday, September 17th. Finally, Cantor Fitzgerald raised shares of Lemonade to a "strong-buy" rating in a report on Wednesday, August 13th. One analyst has rated the stock with a Strong Buy rating, one has given a Buy rating, one has given a Hold rating and four have given a Sell rating to the stock. According to data from MarketBeat, the company currently has an average rating of "Reduce" and a consensus price target of $41.14.

Lemonade Company Profile

Lemonade, Inc provides various insurance products through various channels in the United States, Europe, and the United Kingdom. Its insurance products include stolen or damaged property, and personal liability that protects its customers if they are responsible for an accident or damage to another person or their property.